1. Home
  2. NHS vs NBP Comparison

NHS vs NBP Comparison

Compare NHS & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuberger Berman High Yield Strategies Fund

NHS

Neuberger Berman High Yield Strategies Fund

HOLD

Current Price

$6.35

Market Cap

203.4M

Sector

Finance

ML Signal

HOLD

NBP

NovaBridge Biosciences American Depositary Shares

N/A

Current Price

$1.74

Market Cap

212.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NHS
NBP
Founded
2003
2014
Country
United States
United States
Employees
N/A
30
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.4M
212.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NHS
NBP
Price
$6.35
$1.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
190.8K
848.9K
Earning Date
01-01-0001
04-07-2026
Dividend Yield
13.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.13
$1.63
52 Week High
$7.75
$5.19

Technical Indicators

Market Signals
Indicator
NHS
NBP
Relative Strength Index (RSI) 44.87 29.10
Support Level $6.35 $1.67
Resistance Level $6.54 $1.95
Average True Range (ATR) 0.07 0.11
MACD 0.02 0.01
Stochastic Oscillator 59.46 20.74

Price Performance

Historical Comparison
NHS
NBP

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

About NBP NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Share on Social Networks: